Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease.

Abstract : Parkinson's disease (PD) is a neurodegenerative disorder that leads to destruction of the midbrain dopaminergic (DA) neurons. This phenomenon is related to apoptosis and its activation can be blocked by the pituitary adenylate cyclase-activating polypeptide (PACAP). Growing evidence indicates that autophagy, a self-degradation activity that cleans up the cell, is induced during the course of neurodegenerative diseases. However, the role of autophagy in the pathogenesis of neuronal disorders is yet poorly understood and the potential ability of PACAP to modulate the related autophagic activation has never been significantly investigated. Hence, we explored the putative autophagy-modulating properties of PACAP in in vitro and in vivo models of PD, using the neurotoxic agents 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), respectively, to trigger alterations of DA neurons. In both models, following the toxin exposure, PACAP reduced the autophagic activity as evaluated by the production of LC3 II, the modulation of the p62 protein levels, and the formation of autophagic vacuoles. The ability of PACAP to inhibit autophagy was also observed in an in vitro cell assay by the blocking of the p62-sequestration activity produced with the autophagy inducer rapamycin. Thus, the results demonstrated that autophagy is induced in PD experimental models and that PACAP exhibits not only anti-apoptotic but also anti-autophagic properties.
Type de document :
Article dans une revue
BBA - Biochimica et Biophysica Acta, Elsevier, 2016, 1862 (4), pp.688-95. 〈10.1016/j.bbadis.2016.01.005 〉
Liste complète des métadonnées

https://hal-riip.archives-ouvertes.fr/pasteur-01351354
Contributeur : Michel Courcelles <>
Soumis le : mercredi 3 août 2016 - 15:19:37
Dernière modification le : lundi 8 octobre 2018 - 17:44:05

Identifiants

Citation

Asma Lamine-Ajili, Ahmed M Fahmy, Myriam Létourneau, David Chatenet, Patrick Labonté, et al.. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease.. BBA - Biochimica et Biophysica Acta, Elsevier, 2016, 1862 (4), pp.688-95. 〈10.1016/j.bbadis.2016.01.005 〉. 〈pasteur-01351354〉

Partager

Métriques

Consultations de la notice

45